US2022031925A1PendingUtilityA1

Centrifuge

Assignee: DSM IP ASSETS BVPriority: Nov 19, 2010Filed: Oct 14, 2021Published: Feb 3, 2022
Est. expiryNov 19, 2030(~4.3 yrs left)· nominal 20-yr term from priority
B04B 5/0442A61M 1/3693B04B 11/04B04B 7/08A61M 1/3698B04B 2005/0485B04B 1/02A61M 1/3696B04B 5/0407B01D 21/34B01D 2221/10B01D 21/262B04B 1/18B04B 1/14B04B 2005/045A61M 2202/0429
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Centrifuges are useful to, among other things, remove red blood cells from whole blood and retain platelets and other factors in a reduced volume of plasma. Platelet rich plasma (PRP) and or platelet poor plasma (PPP) can be obtained rapidly and is ready for immediate injection into the host. Embodiments may include valves, operated manually or automatically, to open ports that discharge the excess red blood cells and the excess plasma into separate receivers while retaining the platelets and other factors in the centrifuge chamber. High speeds used allow simple and small embodiments to be used at the patient's side during surgical procedures. The embodiments can also be used for the separation of liquids or slurries in other fields such as, for example, the separation of pigments or lubricants.

Claims

exact text as granted — not AI-modified
1 - 27 . (canceled) 
     
     
         30 . A centrifuge for isolating and concentrating a fraction of a biologic liquid mixture comprising:
 a. a chamber having a longitudinal axis, a first end, a second end, and a sidewall extending between said first end and said second end, wherein at least a portion of said sidewall is transparent;   b. a first port provided in said chamber at a first radial distance from said longitudinal axis, and in fluid communication with a first valve;   c. a second port provided in said chamber at a second radial distance from said longitudinal axis, and in fluid communication with a second valve, said second radial distance being less than said first radial distance;   d. a motor configured to rotate said chamber about said longitudinal axis and thereby produce a centrifugal field;   wherein the sidewall is configured to direct toward the first port a biologic liquid mixture that is present in the chamber and experiencing a centrifugal field.   
     
     
         31 . The centrifuge of  claim 30 , wherein the sidewall extends from the first end to the second end in a first direction that is away from the longitudinal axis. 
     
     
         32 . The centrifuge of  claim 30 , wherein the sidewall extends from the first end to the second end in a second direction that is toward the longitudinal axis. 
     
     
         33 . The centrifuge of  claim 30 , wherein the sidewall extends in a first direction from the first end to the second end that is away from the longitudinal axis, and the sidewall extends in a second direction from the first end to the second end that is toward the longitudinal axis. 
     
     
         34 . The centrifuge of  claim 33 , wherein the first radial distance is between the portion of the sidewall that extends in the first direction and the portion of the sidewall that extends in the second direction. 
     
     
         35 . The centrifuge of  claim 30 , wherein the chamber is disk-shaped. 
     
     
         36 . The centrifuge of  claim 30 , wherein the first port comprises a bore through the sidewall of the chamber. 
     
     
         37 . The centrifuge of  claim 30 , wherein the first port comprises an annular passageway. 
     
     
         38 . The centrifuge of  claim 30 , wherein the first port is in fluid communication with a first reservoir and the second port is in fluid communication with a second reservoir 
     
     
         39 . The centrifuge of  claim 30 , wherein the first valve or second valve employs a resilient sealing mechanism that slides or pivots in response to a sufficient centrifugal field. 
     
     
         40 . The centrifuge of  claim 30 , wherein the first valve is openable in response to user input. 
     
     
         41 . The centrifuge of  claim 30 , wherein the second valve is openable in response to user input. 
     
     
         42 . A method of isolating and concentrating a fraction of a biologic liquid mixture, comprising the steps of:
 a. providing a centrifuge comprising:
 i. a chamber having a longitudinal axis, a first end, a second end, and a sidewall extending between said first end and said second end, wherein at least a portion of said sidewall is transparent; 
 ii. a first port provided in said chamber at a first radial distance from said longitudinal axis, and in fluid communication with a first valve; 
 iii. a second port provided in said chamber at a second radial distance from said longitudinal axis, and in fluid communication with a second valve, said second radial distance being less than said first radial distance; and 
 iv. a motor configured to rotate said chamber about said longitudinal axis and thereby produce a centrifugal field; 
    wherein the sidewall is configured to direct toward the first port a biologic liquid mixture that is present in the chamber and experiencing a centrifugal field;   b. introducing into the chamber a biologic liquid mixture that is separable into at least a first fraction and a second fraction under centrifugal field;   c. rotating the chamber about the longitudinal axis, thereby separating the biologic mixture into the first fraction and the second fraction;   d. ejecting at least a portion of the first fraction from the chamber through the first port and leaving a residual of the biologic liquid mixture in the chamber; and   e. ejecting at least a portion of the second fraction from the chamber through the second port after performing step d.   
     
     
         43 . The method of  claim 42 , wherein said biologic liquid mixture is blood and said separation of said fractions results in one or more of: at least a 6.3 platelet concentration factor; at least 87% platelet recovery; and at least 92% of red blood cells removed from said biologic liquid mixture. 
     
     
         44 . The method of  claim 42 , further comprising the step of:
 f. collecting at least a portion of said sample remaining within said chamber.   
     
     
         45 . The method of  claim 42 , further comprising between step d and step e, the step of monitoring an interface between said first fraction and said second fraction through said sidewall and executing step d in response to the position of the interface. 
     
     
         46 . The method of  claim 42 , further comprising between step d and step e, the step of detecting an interface occurring between separated constituents of said sample by at least one automatic detector and executing step d in response to a signal produced by the automatic detector. 
     
     
         47 . The method of  claim 42 , wherein step d comprises selectively opening the first valve. 
     
     
         48 . The method of  claim 42 , wherein step e comprises selectively opening the second valve. 
     
     
         49 . The method of  claim 47 , further comprising between step d and step e, the step of closing said first valve.

Join the waitlist — get patent alerts

Track US2022031925A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.